Skip to main content

Only One-Third of Gout Patients Receive Urate-Lowering Drugs

Jan 11, 2019 3:00 am

The most recent analysis of National Health and Nutrition Examination Survey [NHANES] 2007-2016) data shows the prevalence of gout to be 9.3 million in the USA.

Data from 5,467 participants from NHANES 2015-2016, finds gout in 3.9% or  9.2 million US adults.  This includes 5.2% [5.9 million] of men and 2.7% [3.3 million] of  women with gout.

Meoan serum urate levels were higher in men (6.0 mg/dL) thn women (4.8 mg/dL), with  prevalence of  hyperuricemia to be 20% in both.

The prevalences of gout and hyperuricemia is unchanged in the last decade (P for trend >0.05).

The prevalence of urate lowering therapy in gout patients was 33% during 2007-2014 and remained stable over time.

Despite a substantial population burden for gout, only one-third of gout patients are receiving ULT. 

The author has no conflicts of interest to disclose related to this subject

Add new comment

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.